Finance

Lists
Why is INTS down १३.०३%?
Dive Deeper
INTS:NASDAQ
Intensity Therapeutics Inc
US$ २.६७
-१३.०३%
(-०.४०) 1D
नोभेम्बर १७, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INTS...
Open
US$ २.९२
High
US$ २.९६
Low
US$ २.५९
Mkt. cap
८८.१४ लाख
Avg. vol.
१९.१३ हजार
Volume
२१.६८ हजार
52-wk high
US$ १५.००
52-wk low
US$ २.५९
EPS
-US$ ४.४७
Beta
३.०१
Shares outstanding
३३.०१ लाख
No. of employees
५
Open
US$ २.९२
High
US$ २.९६
Low
US$ २.५९
Mkt. cap
८८.१४ लाख
Avg. vol.
१९.१३ हजार
Volume
२१.६८ हजार
52-wk high
US$ १५.००
52-wk low
US$ २.५९
EPS
-US$ ४.४७
Beta
३.०१
Shares outstanding
३३.०१ लाख
No. of employees
५
News stories
From web sources and news partners
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Losers: Software Stocks Lead Session Declines
Traders Union
Traders Union
·
१ घण्टा पहिले
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
About Intensity Therapeutics Inc
CEO-
Employees५
Founded२०१२
HeadquartersShelton, कनेक्टिकट, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 1 analyst giving stock ratings to INTS in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for INTS in the last 3 months
Highest
Current US$ २.६७
US$ ७.०० (+१६२.१७%)
Average
US$ ७.०० (+१६२.१७%)
Lowest
US$ ७.०० (+१६२.१७%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
US$ ७.००
+१६२.२%
11/06/2026
James Molloy
Alliance Global Partners
Buy
Reiterated
US$ १५.००
+४६१.८%
08/11/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Upgraded
US$ २०.००
+६४९.१%
03/30/2026
Matthew Venezia
Alliance Global Partners
Buy
Reiterated
US$ ३०.००
+१,०२३.६%
03/30/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१५.०२ लाख
११.९५ लाख
१८.३३ लाख
२४.२९ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१६.३८ लाख
१३.३१ लाख
१२.५१ लाख
११.९४ लाख
Operating expense
३१.४० लाख
२५.२६ लाख
३०.८४ लाख
३६.२३ लाख
Total operating expenses
३१.४० लाख
२५.२६ लाख
३०.८४ लाख
३६.२३ लाख
Operating income
-३१.४० लाख
-२५.२६ लाख
-३०.८४ लाख
-३६.२३ लाख
Other non operating income
१.०० हजार
-२.०० हजार
-
-३.०० हजार
EBT including unusual items
-३०.५१ लाख
-२४.३४ लाख
-३०.०७ लाख
-३५.४४ लाख
EBT excluding unusual items
-३०.५१ लाख
-२४.३४ लाख
-३०.०७ लाख
-३५.४४ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-३०.५१ लाख
-२४.३४ लाख
-३०.०७ लाख
-३५.४४ लाख
Net profit margin
-
-
-
-
Earnings per share
-
-०.९६
-१.११
-१.०९
Interest and investment income
८८.०० हजार
९४.०० हजार
७७.०० हजार
८२.०० हजार
Interest expense
-
-
-
-
Net interest expenses
८८.०० हजार
९४.०० हजार
७७.०० हजार
८२.०० हजार
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू